GenTealSevere (Novartis Pharmaceuticals Corporation)


Welcome to the PulseAid listing for the GenTeal drug offered from Novartis Pharmaceuticals Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Novartis Pharmaceuticals Corporation
NON-PROPRIETARY NAME: HYPROMELLOSE
SUBSTANCE NAME: HYPROMELLOSE 2910 (4000 MPA.S)
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: OPHTHALMIC
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2009-09-14
END MARKETING DATE: 0000-00-00


GenTeal Severe HUMAN OTC DRUG Details:

Item DescriptionGenTeal Severe from Novartis Pharmaceuticals Corporation
LABELER NAME: Novartis Pharmaceuticals Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 0.003(g/g)
START MARKETING DATE: 2009-09-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0078-0429_6e8fbf40-9e2b-f93c-71b9-9f7b1fc36429
PRODUCT NDC: 0078-0429
APPLICATION NUMBER: part349

Other HYPROMELLOSE 2910 (4000 MPA.S) Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alcon Laboratories, Inc.Isopto Tears
HUB Pharmaceuticals, LLCGoniovisc
Novartis Pharmaceutical CorporationGenTeal
Novartis Pharmaceuticals CorporationGenTeal
OCuSOFT, Inc.retaine HPMC